[1]
2018. Evaluation of risk factors in patients with breast cancer in stages III and IV: comparison of Cox and Fine-Grey competing risk regression models. Biomedical Research and Therapy. 5, 02 (Feb. 2018), 2022–2033. DOI:https://doi.org/10.15419/bmrat.v5i02.417.